Duration of treatment with 5-aminosalicylic acid compounds

World Journal of Gastroenterology

Volumn 13, Issue 32, 2007, Pages 4310-4315

  Moshkovska, T ^a   Mayberry, J F ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

5 aminosalicylic acid compounds; Sulphasalazine mesalazine adherance trials; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; MESALAZINE; NEW DRUG; PLACEBO; SALAZOSULFAPYRIDINE;

ABSENCE OF SIDE EFFECTS; ANTIINFLAMMATORY ACTIVITY; CLINICAL ASSESSMENT; CLINICAL STUDY; CLINICAL TRIAL; CROHN DISEASE; DRUG RESEARCH; HUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; RELAPSE; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS AS TOPIC; COLITIS, ULCERATIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTORY, 20TH CENTURY; HUMANS; MESALAMINE; RECURRENCE; TIME FACTORS;

EID: 34548475078     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i32.4310     Document Type: Review

References (26)

1. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 Suppl 5: V1-V16
2. Svartz N. Salazopyrin, a new Sulfanilamide preparation. A. Therapeutic results in rheumatic polyarthritis. B. Therapeutic results in ulcerative colitis. C. Toxic manifestations in treatment with sulphanilamide preparations. Acta. Med Scand 1942; 110: 577-598
3. Cochrane AL. Effectiveness and Efficiency. Random Reflections on Health Services. 1st ed. London Nuffield Provincial Hospitals Trust, 1972: 21-25
4. BARON JH, Connel AM, Lennard-Jones JE, Jones FA. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. Lancet 1962; 1: 1094-1096
5. Dick AP, Grayson MJ, Carpenter RG, Petrie A. Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 1964; 5: 437-442
6. Riis P, Anthonisen P, Wulff HR, Folkenborg O, Bonnevie O, Binder V. The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year. Scand J Gastroenterol 1973; 8: 71-74
7. Dissanayake AS, Truelove SC. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut 1973; 14: 923-926
8. Dickinson RJ, King A, Wight DG, Hunter JO, Neale G. Is continuous sulfasalazine necessary in the management of patients with ulcerative colitis? Results of a preliminary study. Dis Colon Rectum 1985; 28: 929-930
9. Sutherland L, Roth D, Beck P, May G, Makiyama K. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2002; CD000544
10. Nilsson A, Danielsson A, Lofberg R, Benno P, Bergman L, Fausa O, Florholmen J, Karvonen AL, Kildebo S, Kollberg B. Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study. Am J Gastroenterol 1995; 90: 381-387
11. O'Donoghue DP, Dawson AM, Powell-Tuck J, Bown RL, Lennard-Jones JE. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet 1978; 2: 955-957
12. Vilien M, Dahlerup JF, Munck LK, Norregaard P, Gronbaek K, Fallingborg J. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year. Aliment Pharmacol Ther 2004; 19: 1147-1152
13. Hawthorne AB, Logan RF, Hawkey CJ, Foster PN, Axon AT, Swarbrick ET, Scott BB, Lennard-Jones JE. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 1992; 305: 20-99
14. Ardizzone S, Petrillo M, Imbesi V, Cerutti R, Bollani S, Bianchi Porro G. Is maintenance therapy always necessary for patients with ulcerative colitis in remission? Aliment Pharmacol Ther 1999; 13: 373-379
15. Ley P. Communicating with Patients. Improving Communication Satisfaction and Compliance. 1st ed. London: Routledge, 1988; 59-61
16. Bardazzi G, d'Albasio G, Bonanomi AG, Trallori G, Messori A, Amorosi A, Bartoletti L, Morettini A, Pacini F. Intermittent versus continuous 5-aminosalicylic acid treatment for maintaining remission in ulcerative colifis. Ital J Gastroenterol 1994; 26: 334-337
17. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colifis. Am J Gastroenterol 2001; 96: 2929-2933
18. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1994; 271: 59-63
19. Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, Dobkin PL. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003; 98: 1535-1544
20. Rubin GP, Hungin AP, Chinn DJ, Dwarakanath D. Quality of life in patients with established inflammatory bowel disease: a UK general practice survey. Aliment Pharmacol Ther 2004; 19: 529-535
21. Stone MA, Mayberry JF, Baker R. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol 2003; 15: 1275-1280
22. Horne R. Adherence to medication: a review of existing research. In: Myers LB. Midence K Adherence to Treatment in Medical Conditions. Amsterdam: Taylor and Francis, 1998: 285-310
23. Jones HW, Grogono J, Hoare AM. Acute colitis in a district general hospital. Br Med J (Clin Res Ed) 1987; 294: 683-684
24. Moody GA, Jayanthi V, Probert CS, Mac Kay H, Mayberry JF. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 1996; 8: 1179-1183
25. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000; 14: 145-153
26. Pinczowski V, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 1994; 107: 117-120